sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has disclosed its interests and positions in Mural Oncology plc, as required under Rule 8.3 of the Irish Takeover Panel Act. The form, dated October 3, 2025, reveals that Vanguard holds 288,539 ordinary shares of Mural Oncology, representing a 1.67% interest in the company's securities.
No dealings in cash-settled or stock-settled derivatives are reported, maintaining Vanguard's disclosed position solely in ordinary shares. Over the reporting period, Vanguard purchased an additional 80 shares at a price of 2.08 USD per share.
No additional agreements, inducements, or derivative positions were noted, simplifying Vanguard's position to direct equity ownership. The company confirmed the absence of related indemnity or option arrangements.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.